Vertex Pharmaceuticals Announces Webcast of its Presentation at the Lazard Capital Markets Annual Healthcare Conference

CAMBRIDGE, Mass.--(Business Wire)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will
webcast its presentation at the Lazard Capital Markets 6th Annual Healthcare
Conference on Tuesday, November 17, 2009 at 2:40 p.m. EST.

The presentation will be webcast live and may be accessed from `Events &
Presentations` on the home page of Vertex`s website at www.vrtx.com. A replay of
the webcast will also be available on the Company`s website for two weeks
following each presentation. To ensure a timely connection, it is recommended
that users register at least 15 minutes prior to the scheduled webcast.

About Vertex

Vertex Pharmaceuticals Incorporated is a global biotechnology company committed
to the discovery and development of breakthrough small molecule drugs for
serious diseases. The Company`s strategy is to commercialize its products both
independently and in collaboration with major pharmaceutical companies. Vertex`s
product pipeline is focused on viral diseases, cystic fibrosis, inflammation,
autoimmune diseases, cancer, and pain. Vertex co-discovered the HIV protease
inhibitor, Lexiva, with GlaxoSmithKline.

Lexiva is a registered trademark of the GlaxoSmithKline group of companies.

Vertex`s press releases are available at www.vrtx.com.

(VRTX-WEB)

Vertex Pharmaceuticals Incorporated
Lora Pike, 617-444-6755
Associate Director, Investor Relations

Copyright Business Wire 2009